Jaguar8 commented on a stock · Jul 11 20:04

NEWS

STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results

Positive

Estimated Q2 2024 revenue between $8.0 million and $8.4 million.

Growth in the domestic installed base of TheraClear®X devices from 104 to 117 units.

Cash, cash equivalents, and restricted cash of $6.8 million.

Strategic initiatives to drive device utilization and direct-to-consumer activities.

Increased media coverage potentially enhancing market awareness.

Negative

Decline in the domestic installed base of XTRAC® devices from 907 to 881 units.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3170 Views

Comment

Spread kindness and love. Life is short. Don’t let greed eat you.

3485Followers

72Following

38KVisitors